Testing Ways to Invite Adults With Uncontrolled Hypertension to a Pharmacist Visit
Tests letters, postcards and calls inviting adults with uncontrolled hypertension to pharmacist visits.
Key facts
- Who runs it
- Columbia University
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Engaging Patients in Adherence Interventions Using Behavioral Science
- Status
- Enrolling by invitation
- People taking part
- 584 people, planned
- Started
- 8 Nov 2024
- Expected to end
- 30 Sept 2027
- Type of study
- Interventional, 8 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Primer postcard
- Control recruitment letter
- Behavioral theory-informed recruitment letter
- 2 phone calls
- 4 phone calls
- Record updated
- 9 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with high blood pressure that is not under control, who do not take at least one of their blood pressure medicines as prescribed. It tests ways to invite them to see a clinical pharmacist.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Diagnosis of hypertension. Blood pressure at the most recent office visit is 140/90 mmHg or higher.
- Earlier treatment
- Prescribed at least one blood pressure medication. Not taking at least one of them as prescribed, shown by pharmacy records (proportion of days covered <80% in the last 6 months).
Main reasons for not taking part
- Does not speak English or Spanish
- Pregnancy
- Dementia
- Terminal conditions
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age 18 years or older
- Receive care at a Columbia-affiliated primary care clinic in the Ambulatory Care Network
- Diagnosis of hypertension
- Office BP >=140/90 mmHg at most recent office visit
- Prescribed at least one blood pressure medication
- Nonadherent to at least one blood pressure medication as per pharmacy dispense records (proportion of days covered <80% to at least one eligible medication in last 6 months)
Who cannot take part
- Pregnancy, dementia or terminal conditions as per ICD-10 codes
- Do not speak English or Spanish
Where in United States
- Columbia University Irving Medical CenterNew York, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The overarching goal of the proposed research is to prepare an evidence-based clinical pharmacist-delivered medication adherence intervention for sustainable implementation and dissemination. Because the effectiveness of the intervention has already been demonstrated in a NIH Stage Model Stage 4 trial called STIC2IT, this study will include an NIH Stage Model Stage 5 Effectiveness-Implementation Type 3 Hybrid design, in which the primary focus is on testing different implementation methods, while secondarily observing clinical effects. The overarching hypothesis is that investigators can identify the most impactful elements of a behavioral theory-informed recruitment approach, which can be replicable across clinical settings.
Read full original descriptionShow less
Accordingly, this study will perform testing of behaviorally-informed recruitment approaches in a primary care setting that serves patients from under-resourced communities. Patients will be English or Spanish speaking adults ≥18 years of age identified through the electronic health record (EHR) as having a primary care clinician at the participating practice as well as uncontrolled hypertension and suboptimal adherence to blood pressure medications based on pharmacy fill data linked to the electronic health record (EHR). The primary care clinicians of eligible patients identified through the EHR will have the opportunity to opt-out any patients they wish not to be included. Patients will then be randomized to each of the following conditions, such that there will be 8 total arms: (1) inclusion of a mailer primer (yes/no), (2) the most successful recruitment letter from a preliminary study using prospect theory (versus the control letter), and (3) intensity of the intervention outreach (up to 4 calls vs. up to 2 calls).
Patients across all arms who agree to be scheduled will receive an appointment with one of the clinical pharmacists trained in the brief negotiated interviewing approach used in the STIC2IT trial. The primary outcome will be completion of a clinical pharmacist appointment within 12 weeks of randomization. Key secondary outcomes will include scheduled visit rates, no-show rates for scheduled appointments, pharmacy fill adherence to statins and blood pressure medications over the 3-month follow-up, and clinical outcomes, including blood pressure as per EHR data in the 3 months after randomization.
The 8 groups in the trial
- Postcard/behavioral letter/4 callsExisting treatment, for comparison
Mailed a priming postcard, followed by a prospect theory-informed recruitment letter, followed by up to 4 phone call attempts to schedule patient to attend an adherence counseling session with a clinical pharmacist trained in brief negotiated interviewing
Treatment: Primer postcard, Behavioral theory-informed recruitment letter, and 4 phone calls
- No postcard/behavioral letter/4 callsExisting treatment, for comparison
Mailed a prospect-theory informed recruitment letter that is not preceded by a priming postcard, followed by up to 4 phone call attempts to schedule patient to attend an adherence counseling session with a clinical pharmacist trained in brief negotiated interviewing
Treatment: Behavioral theory-informed recruitment letter and 4 phone calls
- Postcard/control letter/4 callsExisting treatment, for comparison
Mailed a priming postcard, followed by a usual care control recruitment letter, followed by up to 4 phone call attempts to schedule patient to attend an adherence counseling session with a clinical pharmacist trained in brief negotiated interviewing
Treatment: Primer postcard, Control recruitment letter, and 4 phone calls
- No postcard/control letter/4 callsExisting treatment, for comparison
Mailed a usual care control recruitment letter that is not preceded by a priming postcard, followed by up to 4 phone call attempts to schedule patient to attend an adherence counseling session with a clinical pharmacist trained in brief negotiated interviewing
Treatment: Control recruitment letter and 4 phone calls
- Postcard/behavioral letter/2 callsExisting treatment, for comparison
Mailed a priming postcard, followed by a prospect theory-informed recruitment letter, followed by up to 2 phone call attempts to schedule patient to attend an adherence counseling session with a clinical pharmacist trained in brief negotiated interviewing
Treatment: Primer postcard, Behavioral theory-informed recruitment letter, and 2 phone calls
- No postcard/behavioral letter/2 callsExisting treatment, for comparison
Mailed a prospect theory-informed recruitment letter that is not preceded by a priming postcard, followed by up to 2 phone call attempts to schedule patient to attend an adherence counseling session with a clinical pharmacist trained in brief negotiated interviewing
Treatment: Behavioral theory-informed recruitment letter and 2 phone calls
- Postcard/control letter/2 callsExisting treatment, for comparison
Mailed a priming postcard, followed by a usual care control recruitment letter, followed by up to 2 phone call attempts to schedule patient to attend an adherence counseling session with a clinical pharmacist trained in brief negotiated interviewing
Treatment: Primer postcard, Control recruitment letter, and 2 phone calls
- No postcare/control letter/2 callsExisting treatment, for comparison
Mailed a usual care control recruitment letter that is not preceded by a priming postcard, followed by up to 2 phone call attempts to schedule patient to attend an adherence counseling session with a clinical pharmacist trained in brief negotiated interviewing
Treatment: Control recruitment letter and 2 phone calls
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Optimizing Recruitment Methodology for Medication Adherence Interventions: The ENGaging Patients in Adherence Interventions UsinG Behavioral SciencE (ENGAGE) Randomized Factorial Trial
- Plain-language title
- Testing Ways to Invite Adults With Uncontrolled Hypertension to a Pharmacist VisitGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 December 2025